147 related articles for article (PubMed ID: 9857366)
1. Sertoli cell transplants: their use in the treatment of neurodegenerative disease.
Willing AE; Cameron DF; Sanberg PR
Mol Med Today; 1998 Nov; 4(11):471-7. PubMed ID: 9857366
[TBL] [Abstract][Full Text] [Related]
2. Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats.
Sanberg PR; Borlongan CV; Othberg AI; Saporta S; Freeman TB; Cameron DF
Nat Med; 1997 Oct; 3(10):1129-32. PubMed ID: 9334725
[TBL] [Abstract][Full Text] [Related]
3. Sertoli cells enhance the survival of co-transplanted dopamine neurons.
Willing AE; Othberg AI; Saporta S; Anton A; Sinibaldi S; Poulos SG; Cameron DF; Freeman TB; Sanberg PR
Brain Res; 1999 Mar; 822(1-2):246-50. PubMed ID: 10082904
[TBL] [Abstract][Full Text] [Related]
4. Use of Sertoli cell transplants to provide local immunoprotection for tissue grafts.
Halberstadt C; Emerich DF; Gores P
Expert Opin Biol Ther; 2004 Jun; 4(6):813-25. PubMed ID: 15174964
[TBL] [Abstract][Full Text] [Related]
5. CNS immunological modulation of neural graft rejection and survival.
Borlongan CV; Stahl CE; Cameron DF; Saporta S; Freeman TB; Cahill DW; Sanberg PR
Neurol Res; 1996 Aug; 18(4):297-304. PubMed ID: 8875445
[TBL] [Abstract][Full Text] [Related]
6. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain.
Sanberg PR; Borlongan CV; Saporta S; Cameron DF
Nat Biotechnol; 1996 Dec; 14(13):1692-5. PubMed ID: 9634853
[TBL] [Abstract][Full Text] [Related]
7. Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study.
Rodriguez AI; Willing AE; Saporta S; Cameron DF; Sanberg PR
Neurotox Res; 2003; 5(6):443-50. PubMed ID: 14715448
[TBL] [Abstract][Full Text] [Related]
8. Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum.
Willing AE; Sudberry JJ; Othberg AI; Saporta S; Poulos SG; Cameron DF; Freeman TB; Sanberg PR
Brain Res Bull; 1999 Mar; 48(4):441-4. PubMed ID: 10357077
[TBL] [Abstract][Full Text] [Related]
9. Preparation of cell suspensions for co-transplantation: methodological considerations.
Othberg AI; Willing AE; Saporta S; Cameron DF; Sanberg PR
Neurosci Lett; 1998 May; 247(2-3):111-4. PubMed ID: 9655605
[TBL] [Abstract][Full Text] [Related]
10. Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression.
Saporta S; Cameron DF; Borlongan CV; Sanberg PR
Exp Neurol; 1997 Aug; 146(2):299-304. PubMed ID: 9270038
[TBL] [Abstract][Full Text] [Related]
11. The testicular-derived Sertoli cell: cellular immunoscience to enable transplantation.
Emerich DF; Hemendinger R; Halberstadt CR
Cell Transplant; 2003; 12(4):335-49. PubMed ID: 12911122
[TBL] [Abstract][Full Text] [Related]
12. Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results.
Fink JS; Schumacher JM; Ellias SL; Palmer EP; Saint-Hilaire M; Shannon K; Penn R; Starr P; VanHorne C; Kott HS; Dempsey PK; Fischman AJ; Raineri R; Manhart C; Dinsmore J; Isacson O
Cell Transplant; 2000; 9(2):273-8. PubMed ID: 10811399
[TBL] [Abstract][Full Text] [Related]
13. Sertoli cell grafts for Huntington's disease. An opinion.
Emerich DF
Neurotox Res; 2004; 5(8):567. PubMed ID: 15111233
[TBL] [Abstract][Full Text] [Related]
14. Adult human neural stem cells for autologous cell replacement therapies for neurodegenerative disorders.
Galvin KA; Jones DG
NeuroRehabilitation; 2006; 21(3):255-65. PubMed ID: 17167195
[TBL] [Abstract][Full Text] [Related]
15. Survival of rat or mouse ventral mesencephalon neurons after cotransplantation with rat sertoli cells in the mouse striatum.
Shamekh R; Newcomb J; Mallery J; Cassady CJ; Saporta S; Cameron DF; Sanberg PR; Willing AE
Cell Transplant; 2005; 14(8):551-64. PubMed ID: 16358409
[TBL] [Abstract][Full Text] [Related]
16. [Restoration of brain function by cell transplantation].
Kakishita K; Nakao N; Itakura T
Nihon Rinsho; 2003 Mar; 61(3):457-62. PubMed ID: 12701173
[TBL] [Abstract][Full Text] [Related]
17. Current status of neuronal cell xenotransplantation.
Vadori M; Aron Badin R; Hantraye P; Cozzi E
Int J Surg; 2015 Nov; 23(Pt B):267-272. PubMed ID: 26403068
[TBL] [Abstract][Full Text] [Related]
18. [10 years of substitution therapy for neurodegenerative diseases using fetal neuron grafts: a positive outcome but with questions for the future].
Peschanski M
J Soc Biol; 2001; 195(1):51-5. PubMed ID: 11530501
[TBL] [Abstract][Full Text] [Related]
19. The production and use of cells as therapeutic agents in neurodegenerative diseases.
Isacson O
Lancet Neurol; 2003 Jul; 2(7):417-24. PubMed ID: 12849120
[TBL] [Abstract][Full Text] [Related]
20. Sertoli cells induce systemic donor-specific tolerance in xenogenic transplantation model.
Shamekh R; El-Badri NS; Saporta S; Pascual C; Sanberg PR; Cameron DF
Cell Transplant; 2006; 15(1):45-53. PubMed ID: 16700329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
